Rothschild
LDC exits Ellis Whittam to Marlowe in £59m deal
Sale ends a four-year holding period for LDC, which owned a minority stake in the company
TDR, private investors to acquire Asda for £6.8bn
Asda was previously in talks with Sainsbury's, which would have paid ТЃ7.3bn for the asset
Palatine invests in NRG
Following the investment, the company will follow a buy-and-build strategy and develop its services
BlackRock-backed THG to launch £920m IPO
Following the listing, the online retailer will have a free float of at least 20%
GED, Oquendo sell GTT to AnaCap
Sale ends a three-year holding period for Ged and Oquendo, which acquired the company from Realza Capital
CVC buys Italian pharma company Genetic
GP deploys capital from CVC Strategic Opportunities II, which held a final close on €4.6bn in July 2019
Kennet V closes on €223m
Registered in February 2018, the fund's original target was тЌ200m, with a hard-cap of тЌ250m
Auster Fund I holds first close on $500m
Auster intends to target equity tickets of $50-200m with the ability to commit larger amounts
Carlyle acquires stake in Envea for €186m EV
Envea reported revenue of €100.4m and an operating profit of €14.7m in FY 2019
KKR to acquire Roompot from PAI
At the beginning of 2020, PAI hired Rothschild to sell the company for an expected valuation of €1bn
Torqx acquires Fabory
Grainger, the vendor of the company, mandated Rothschild to explore a sale process in November 2019
Bridgepoint buys insurance group CEP from JC Flowers
GP invests via Bridgepoint Europe VI, which closed on its €5.7bn hard-cap in December 2017
Parquest Capital sells Homeperf
GP, alongside minority shareholders BNP Paribas, Arkéa and Vivalto, reinvest in the business
Ardian backs Argon & Co
GP deploys capital from Ardian Growth II, which closed on €230m in April 2018, surpassing its target
Chequers Capital carves out EBC from Econocom
GP is currently investing its Chequers Capital XVII fund, which closed on €1.1bn in May 2017
European consumer M&A presents opportunities in Covid-19 chaos
Europe's consumer sector offers pockets of opportunity as the coronavirus pandemic wreaks havoc on M&A
Secondaries sea change: Backing your winners
What was once the preserve of the underperformer is now shifting towards the prized asset
Huntsworth board accepts £524m offer from CD&R
Takeover offer implies an entry multiple of 10.8x adjusted EBITDA of ТЃ48.4m
Five Arrows to sell stake in Dutscher to LBO France
Five Arrows previously acquired a minority stake in Dutscher in 2013
Tikehau closes GP-led secondaries process with Five Arrows
Secondaries process of six balance-sheet assets was tied to the fundraise for Tikehau Growth Equity II
Cerberus sells Covis Pharma to Apollo
Sale ends a nine-year holding period for the GP, which built Covis through a series of acquisitions
Bain Capital, NBRP invest in Engineering
Sale ends a four-year holding period for Apax, which invested in the company via its eight fund
Highlander exits Akomex in management buy-back
Mezzanine Management, which is currently investing from its AMC IV fund, backs the management
Five Arrows Secondary Opportunities V closes on €1bn
Vehicle's predecessor, Five Arrows Principal Investments IV, closed on €451m